Patents by Inventor Hermann LUEBBERT

Hermann LUEBBERT has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Salt polymorph of thioxanthene-9-ylidene-1-methyl piperidine acid addition salts as antimigraine compounds
    Patent number: 9708304
    Abstract: The present invention relates to novel crystal forms of 4-(6-ethoxy-1-methoxy-thioxanthene-9-ylidene)-1-methyl piperidine salts and 4-(6-ethoxy-1-hydroxy-thioxanthene-9-ylidene)-1-methyl piperidine salts; especially to novel crystal forms of 4-(6-ethoxy-1-methoxy-thioxanthene-9-ylidene)-1-methyl piperidine hydrochloride and 4-(6-ethoxy-1-hydroxy-thioxanthene-9-ylidene)-1-methyl piperidine hydrochloride as well as to the use of these salts for preventing or treating migraine or pulmonary hypertension.
    Type: Grant
    Filed: January 31, 2014
    Date of Patent: July 18, 2017
    Assignee: Biofrontera Bioscience GmbH
    Inventors: Beate Schmitz, Hermann Luebbert
  • SALT POLYMORPH OF THIOXANTHENE-9-YLIDENE-1-METHYL PIPERIDINE ACID ADDITION SALTS AS ANTIMIGRAINE COMPOUNDS
    Publication number: 20150376168
    Abstract: The present invention relates to novel crystal forms of 4-(6-ethoxy-1-methoxy-thioxanthene-9-ylidene)-1-methyl piperidine salts and 4-(6-ethoxy-1-hydroxy-thioxanthene-9-ylidene)-1-methyl piperidine salts; especially to novel crystal forms of 4-(6-ethoxy-1-methoxy-thioxanthene-9-ylidene)-1-methyl piperidine hydrochloride and 4-(6-ethoxy-1-hydroxy-thioxanthene-9-ylidene)-1-methyl piperidine hydrochloride as well as to the use of these salts for preventing or treating migraine or pulmonary hypertension.
    Type: Application
    Filed: January 31, 2014
    Publication date: December 31, 2015
    Inventors: Beate SCHMITZ, Hermann LUEBBERT
  • PHARMACEUTICAL AND/OR COSMETIC COMPOSITION FOR TREATING THE SKIN
    Publication number: 20110250239
    Abstract: The present invention concerns the pharmaceutical and cosmetic application of biocolloids, which originate from the mixture of a nanoemulsion and at least one water-soluble plant extract such as an extract from Mahonia aquifolium, wherein the biological effect of the plant ingredients is enhanced by the composition although the nanoemulsion does not function as a carrier system. The biocolloids are especially for the treatment and care of the skin.
    Type: Application
    Filed: April 7, 2011
    Publication date: October 13, 2011
    Applicant: BIOFRONTERA BIOSCIENCE GMBH
    Inventors: Hermann LUEBBERT, Montserrat Foguet ROCA, Mirella GWAREK